Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience
ConclusionsRe-irradiation for recurrent pediatric medulloblastoma can offer some patients disease control, particularly those with focally recurrent disease in the brain. Prospective studies are needed to confirm subgroups of patients who may benefit most from RT2.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Canada Health | Cancer & Oncology | Children | Medulloblastoma | Nanotechnology | Neurology | Pediatrics | Radiation Therapy | Stem Cell Therapy | Stem Cells | Study | Transplants